Evaluation of frizzled class receptor 3 and miR-378 expression levels in cumulus cells of polycystic ovary syndrome women: A case-control study

多囊卵巢综合征患者卵丘细胞中卷曲受体3和miR-378表达水平的评估:一项病例对照研究

阅读:1

Abstract

BACKGROUND: Polycystic ovarian syndrome (PCOS) is a common endocrine disorder that affects women of reproductive age. Recent studies suggest that frizzled class receptor 3 (FZD3) and miR-378 play significant roles in PCOS by affecting oocyte maturation. OBJECTIVE: Considering the importance of FZD3 and miR-378 in ovulation, the present study aimed to determine the expression levels of FZD3 and miR-378 genes in cumulus cells of germinal vesicles and metaphase II oocytes in women with PCOS. MATERIALS AND METHODS: The samples for this case-control study included, randomly selected, 25 women with PCOS who were treated at the Research and Clinical Center for Infertility, Yazd, Iran. The diagnosis of PCOS was made based on the criteria defined in the Rotterdam guidelines. Quantitative real-time polymerase chain reaction determined the expression level of FZD3 and miR-378. RESULTS: This study showed increased expression of FZD3 and miR-378 in cumulus cells of immature oocytes compared to mature oocytes (p  <  0.0001). CONCLUSION: High levels of FZD3 and miR-378 in cumulus cells of immature oocytes can inhibit their maturation. FZD3, a component of the WNT signaling pathway, is overexpressed in immature oocytes and may negatively affect the maturation process. Additionally, miR-378 inhibits oocyte development by targeting and repressing essential genes. Currently, various aspects of microRNA function remain unknown. MiR-378 may exert its regulatory role by directly targeting the FZD3 gene or by targeting other genes and mediators that interact with FZD3 or the protein it encodes. This study may provide a foundation for further investigation of this hypothesis in future research.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。